BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1562718)

  • 1. Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis.
    Elliott S; Taylor K; White S; Rodwell R; Marlton P; Meagher D; Wiley J; Taylor D; Wright S; Timms P
    Blood; 1992 Apr; 79(8):1916-9. PubMed ID: 1562718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse.
    Desangles F; Vilain E; Arborio M; De Revel T; Flandrin G
    Leuk Lymphoma; 1995 Sep; 19(1-2):185-8. PubMed ID: 8574167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
    De Botton S; Chevret S; Sanz M; Dombret H; Thomas X; Guerci A; Fey M; Rayon C; Huguet F; Sotto JJ; Gardin C; Cony Makhoul P; Travade P; Solary E; Fegueux N; Bordessoule D; San Miguel J; Link H; Desablens B; Stamatoullas A; Deconinck E; Geiser K; Hess U; Maloisel F; Castaigne S; Preudhomme C; Chomienne C; Degos L; Fenaux P;
    Br J Haematol; 2000 Dec; 111(3):801-6. PubMed ID: 11122141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
    Corey SJ; Locker J; Oliveri DR; Shekhter-Levin S; Redner RL; Penchansky L; Gollin SM
    Leukemia; 1994 Aug; 8(8):1350-3. PubMed ID: 8057672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone.
    Advani SH; Nair R; Bapna A; Gladstone B; Kadam P; Saikia TK; Parekh PM; Gopal R; Nair CN
    Am J Hematol; 1999 Feb; 60(2):87-93. PubMed ID: 9929098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
    Miyauchi J; Ohyashiki K; Inatomi Y; Toyama K
    Blood; 1997 Jul; 90(2):803-13. PubMed ID: 9226181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    Varghese L; Janckila A; Yam LT
    J Ky Med Assoc; 1999 Feb; 97(2):61-5. PubMed ID: 10073058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia.
    Colović MD; Janković GM; Elezović I; Vidović A; Bila JS; Novak A; Babić D
    Med Oncol; 1997 Jun; 14(2):65-72. PubMed ID: 9330265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation induction therapy with all-trans retinoic acid (ATRA) in a patient with secondary 11q23 leukemia.
    Kakihara T; Tanaka A; Kataoka S; Yamamoto K; Okada R; Watanabe A; Uchiyama M; Kishi K
    J Pediatr Hematol Oncol; 1996 Nov; 18(4):405-8. PubMed ID: 8888753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
    Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn JY; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque JP; Naccache P; Chomienne C; Degos L; Fenaux P
    Leukemia; 2000 Jun; 14(6):1006-13. PubMed ID: 10865965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
    Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
    Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
    Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
    Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
    Laczika K; Mitterbauer G; Korninger L; Knöbl P; Schwarzinger I; Kapiotis S; Haas OA; Kyrle PA; Pont J; Oehler L
    Leukemia; 1994 Jan; 8(1):1-5. PubMed ID: 8289472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of X-linked clonal analysis in acute promyelocytic leukemia.
    Taylor KM; Rodwell RL; Elliott SL; Taylor DL
    Leuk Lymphoma; 1993 Nov; 11(5-6):339-43. PubMed ID: 8124205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.